Literature DB >> 2163903

Distribution of inositol 1,4,5-trisphosphate receptor mRNA in mouse tissues.

T Furuichi1, C Shiota, K Mikoshiba.   

Abstract

Northern blot analysis demonstrated that the concentration of inositol 1,4,5-triphosphate (IP3) receptor mRNA was greatest in cerebellar tissue. Moderate amounts of IP3 mRNA were present in brain tissue without cerebellum and tissue of the thymus, heart, lung, liver, spleen, kidney, and uterus. Small amounts of IP3 receptor mRNA were observed in skeletal muscle and testicular tissue. Regional distribution of IP3 mRNA in various tissues was also examined by in situ hybridization. A considerable amount of IP3 receptor mRNA was located in smooth muscle cells, such as those of the arteries, bronchioles, oviduct and uterus. In addition, secondary oocytes surrounded by Graafian follicles in the ovary were found to have large amounts of IP3 receptor mRNA. The present studies suggest a functional importance of the IP3 second-messenger system in these cell types.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2163903     DOI： 10.1016/0014-5793(90)80294-s

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


  17 in total

1.  The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma.

Authors:  Kazunori Shibao; Michael J Fiedler; Jun Nagata; Noritaka Minagawa; Keiji Hirata; Yoshifumi Nakayama; Yasuko Iwakiri; Michael H Nathanson; Koji Yamaguchi
Journal:  Cell Calcium       Date:  2010-11-13       Impact factor: 6.817

2.  Triadins are not triad-specific proteins: two new skeletal muscle triadins possibly involved in the architecture of sarcoplasmic reticulum.

Authors:  Stéphane Vassilopoulos; Dominique Thevenon; Sophia Smida Rezgui; Julie Brocard; Agnès Chapel; Alain Lacampagne; Joël Lunardi; Michel Dewaard; Isabelle Marty
Journal:  J Biol Chem       Date:  2005-05-31       Impact factor: 5.157

3.  The subtypes of the mouse inositol 1,4,5-trisphosphate receptor are expressed in a tissue-specific and developmentally specific manner.

Authors:  T Nakagawa; H Okano; T Furuichi; J Aruga; K Mikoshiba
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

4.  Skeletal muscle IP3R1 receptors amplify physiological and pathological synaptic calcium signals.

Authors:  Haipeng Zhu; Bula J Bhattacharyya; Hong Lin; Christopher M Gomez
Journal:  J Neurosci       Date:  2011-10-26       Impact factor: 6.167

Review 5.  Calcium and inositol trisphosphate receptors.

Authors:  C W Taylor; D Traynor
Journal:  J Membr Biol       Date:  1995-05       Impact factor: 1.843

6.  Immunogold localization of inositol 1,4,5-trisphosphate receptors and characterization of ultrastructural features of the sarcoplasmic reticulum in phasic and tonic smooth muscle.

Authors:  G F Nixon; G A Mignery; A V Somlyo
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

7.  Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin.

Authors:  H De Smedt; L Missiaen; J B Parys; R H Henning; I Sienaert; S Vanlingen; A Gijsens; B Himpens; R Casteels
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

8.  The calmodulin-binding domain in the mouse type 1 inositol 1,4,5-trisphosphate receptor.

Authors:  M Yamada; A Miyawaki; K Saito; T Nakajima; M Yamamoto-Hino; Y Ryo; T Furuichi; K Mikoshiba
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

9.  Inositol 1,4,5-triphosphate-stimulated calcium release from permeabilized cerebellar granule cells.

Authors:  E M Whitham; R A Challiss; S R Nahorski
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

10.  Human inositol 1,4,5-trisphosphate type-1 receptor, InsP3R1: structure, function, regulation of expression and chromosomal localization.

Authors:  N Yamada; Y Makino; R A Clark; D W Pearson; M G Mattei; J L Guénet; E Ohama; I Fujino; A Miyawaki; T Furuichi
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.